Clinical Trial Update: A Phase 2a Study to Assess Safety & Pharmacokinetics of Sustained Release Sodium Nitrite in Patients With Diabetic Pain [Phase 2]

View source ↗

Summary

Phase 2a trial evaluating safety and pharmacokinetics of sustained-release sodium nitrite in patients with diabetes has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes

Drugs mentioned

• Sustained Release Sodium Nitrite (sodium nitrite (sustained-release formulation))

Snippet

Sponsor: TheraVasc Inc. | Conditions: Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2020-04-24